FDA — authorised 19 December 2014
- Application: NDA206255
- Marketing authorisation holder: GALDERMA LABS LP
- Local brand name: SOOLANTRA
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Ivermectin 1% cream in United States
FDA authorised Ivermectin 1% cream on 19 December 2014
Marketing authorisation
Other Dermatology approved in United States
Frequently asked questions
Is Ivermectin 1% cream approved in United States?
Yes. FDA authorised it on 19 December 2014.
Who is the marketing authorisation holder for Ivermectin 1% cream in United States?
GALDERMA LABS LP holds the US marketing authorisation.